Tema ETFs’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.25M Buy
395,313
+2,559
+0.7% +$12.5K 0.07% 173
2026
Q1
$1.68M Buy
392,754
+148,906
+61% +$830K 0.11% 166
2025
Q4
$2.18M Sell
243,848
-8,674
-3% -$53.7K 0.17% 146
2025
Q3
$934K Buy
252,522
+112,874
+81% +$308K 0.08% 271
2025
Q2
$272K Buy
+139,648
New +$291K 0.07% 154

Other funds holding NUVB

Tema ETFs's NUVB Position: Q2 2026 in Review

Tema ETFs increased its Nuvation Bio (NUVB) stake by 0.65% in Q2 2026, buying an estimated $12.5K and bringing the position to 395,313 shares worth $2.25M. The position accounts for 0.07% of the portfolio, ranked #173.

Tema ETFs first reported a position in NUVB in Q2 2025 and has held it in 5 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Tema ETFs held 395,313 shares of Nuvation Bio worth $2.25M as of Q2 2026.
  • Tema ETFs bought 2,559 Nuvation Bio shares in Q2 2026, an estimated $12.5K.
  • Nuvation Bio made up 0.07% of Tema ETFs's portfolio in Q2 2026, its #173 holding.
  • Tema ETFs first reported a position in Nuvation Bio in Q2 2025 and has held it in 5 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.